BeiGene, Ltd. (BGNE) has shown exceptional revenue growth over the past 3 years, expanding from $1.4B to $5.3B (average +56.3%/yr). Net income reached $287M, reflecting exceptional earnings expansion at +75.8%/yr on average. The net profit margin is 5.4%, which is moderate. the company was profitable in 1 out of the last 4 years tracked. The gross margin is 87.5% (high), with a +123.6pp trend over the period. With a $20B market cap and MOAT composite score of 80/100, the company has a strong competitive position.
Criteria proven by this page:
Overall SharesGrow Score: 73/100 with 5/7 criteria passed.